RETRACTED to: Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin (Critical Reviews in Microbiology, (2017), 43, 1, (43-61), 10.3109/1040841X.2016.1160867);Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin

Critical Reviews in Microbiology

Volumn 43, Issue 1, 2017, Pages 43-61

  Mathlouthi, Najla ^a,b,c   Al Bayssari, Charbel ^b   Bakour, Sofiane ^b   Rolain, Jean Marc ^b   Chouchani, Chedly ^a,c  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF CARTHAGE   (Tunisia)

Author keywords

Carbapenemases; Gram negative bacteria; Mediterranean countries

Indexed keywords

CARBAPENEMASE; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MEDITERRANEAN SEA; MICROBIAL DIVERSITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; CLASSIFICATION; ENZYMOLOGY; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; SOUTHERN EUROPE;

BACTERIAL PROTEINS; BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MEDITERRANEAN REGION;

EID: 85008502621     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.1080/1040841X.2017.1326488     Document Type: Erratum

References (228)

1. Abdelaziz MO, Bonura C, Aleo A, et al. (2012). OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010. J Clin Microbiol 50:2489–91.
2. Abdelaziz MO, Bonura C, Aleo A, et al. (2013a). NDM-1- and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt, 2012. J Clin Microbiol 50:2489–91.
3. Abdelaziz MO, Bonura C, Aleo A, et al. (2013b). Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt. Microbiol Immunol 57:391–5.
4. Adler A, Hussein O, Ben-David D, et al. (2015). Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing enterobacteriaceae in post-acute-care hospitals in Israel, 2008–13. J Antimicrob Chemother 70:89–92.
5. Adler A, Shklyar M, Schwaber MJ, et al. (2011). Introduction of OXA-48-producing enterobacteriaceae to Israeli hospitals by medical tourism. J Antimicrob Chemother 66:2763–6.
6. Agabou A, Pantel A, Ouchenane Z, et al. (2014). First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria. Eur J Clin Microbiol Infect Dis 33:1641–6.
7. Agodi A, Voulgari E, Barchitta M, et al. (2011). Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 49:3986–9.
8. Aktas Z, Bal C, Midilli K, et al. (2006). First IMP-1-producing Klebsiella pneumoniae isolate in Turkey. Clin Microbiol Infect 12:695–6.
9. Al-Agamy MH, Khalaf NG, Tawfick MM, et al. (2014). Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22:49–54.
10. Al Bayssari BC, Diene SM, Loucif L, et al. (2014). Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of OprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon. Antimicrob Agents Chemother 58:4966–70.
11. Al-Hassan L, El MH, Amyes SG. (2013). Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect 19:1082–8.
12. Al-Hassan L, Opazo A, Lopes B, et al. (2015). Variations in IS6 promoters alter the expression of carbapenemresistance in related strains of Acinetobacter baumannii. J Glob Antimicrob Resist 3:5–8.
13. Altoparlak U, Aktas F, Celebi D, et al. (2005). Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns 31:707–10.
14. Ambretti S, Gaibani P, Caroli F, et al. (2010). A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. New Microbiol 33:281–2.
15. Armand-Lefevre L, Angebault C, Barbier F, et al. (2013). Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488–95.
16. Aschbacher R, Doumith M, Livermore DM, et al. (2008). Linkage of acquired quinolone resistance (QnrS1) and metallo-beta-lactamase (BlaVIM-1) genes in multiple species of enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 61:515–23.
17. Aubron C, Poirel L, Fortineau N, et al. (2005). Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital. Microb Drug Resist 11:254–9.
18. Bahar G, Mazzariol A, Koncan R, et al. (2004). Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J Antimicrob Chemother 54:282–3.
19. Bakour S, Kempf M, Touati A, et al. (2012). Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria. J Med Microbiol 61:1341–3.
20. Bakour S, Olaitan AO, Ammari H, et al. (2015a). Emergence of colistin- and carbapenem-resistant Acinetobacter baumannii ST2 clinical isolate in Algeria:first case report. Microb Drug Resist 21:279–85.
21. Bakour S, Sahli F, Touati A, Rolain JM. (2015b). Emergence of KPC-producing Klebsiella pneumoniae ST512 isolated from cerebrospinal fluid of a child in Algeria. New Microbes New Infect 3:34–6.
22. Bakour S, Touati A, Bachiri T, et al. (2014). First report of 16S RRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals. J Infect Chemother 20:696–701.
23. Barguigua A, El OF, Lakbakbi El YF, et al. (2013a). First report of a Klebsiella pneumoniae strain coproducing NDM-1, VIM-1 and OXA-48 carbapenemases isolated in Morocco. APMIS 121:675–7.
24. Barguigua A, El OF, Talmi M, et al. (2012). Emergence of carbapenem-resistant enterobacteriaceae isolates in the Moroccan community. Diagn Microbiol Infect Dis 73:290–1.
25. Barguigua A, El OF, Talmi M, et al. (2013b). Prevalence and types of extended spectrum beta-lactamases among urinary Escherichia coli isolates in Moroccan community. Microb Pathog 61–62:16–22.
26. Baroud M, Dandache I, Araj GF, et al. (2013). Underlying mechanisms of carbapenem resistance in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon:role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 41:75–9.
27. Bedenic B, Mazzariol A, Plecko V, et al. (2012). First report of KPC-producing Klebsiella pneumoniae in Croatia. J Chemother 24:237–9.
28. Belotti PT, Thabet L, Laffargue A, et al. (2015). Description of an original integron encompassing BlaVIM-2, QnrVC1 and genes encoding bacterial group II intron proteins in Pseudomonas aeruginosa. J Antimicrob Chemother 70:2237–40.
29. Ben NA, Decre D, Compain F, et al. (2013). Emergence of NDM-1 in association With OXA-48 in Klebsiella pneumoniae from Tunisia. Antimicrob Agents Chemother 57:4089–90.
30. Benouda A, Touzani O, Khairallah MT, et al. (2010). First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann Trop Med Parasitol 104:327–30.
31. Beyrouthy R, Robin F, Dabboussi F, et al. (2014). Carbapenemase and virulence factors of enterobacteriaceae in North Lebanon between 2008 and 2012:evolution via endemic spread of OXA-48. J Antimicrob Chemother 69:2699–705.
32. Birgy A, Doit C, Mariani-Kurkdjian P, et al. (2011). Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol 49:3085–7.
33. Bogaerts P, Bouchahrouf W, de Castro RR, et al. (2011). Emergence of NDM-1-producing enterobacteriaceae in Belgium. Antimicrob Agents Chemother 55:3036–8.
34. Bonnin RA, Nordmann P, Potron A, et al. (2011). Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 55:349–54.
35. Bonnin RA, Ocampo-Sosa AA, Poirel L, et al. (2012a). Biochemical and genetic characterization of carbapenem-hydrolyzingβ-lactamase OXA-229 from Acinetobacter bereziniae. Antimicrob Agents Chemother 56:3923–7.
36. Bonnin RA, Poirel L, Naas T, et al. (2012b). Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect 18:E362–5.
37. Borer A, Saidel-Odes L, Riesenberg K, et al. (2009). Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30:972–6.
38. Bosnjak Z, Bedenic B, Mazzariol A, et al. (2010). VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia. Scand J Infect Dis 42:193–7.
39. Boulanger A, Naas T, Fortineau N, et al. (2012). NDM-1-producing Acinetobacter baumannii from Algeria. Antimicrob Agents Chemother 56:2214–15.
40. Cakirlar FK, Ciftci IH, Gonullu N. (2015). OXA-type carbapenemases and susceptibility of colistin and tigecycline among carbapenem-resistant Acinetobacter baumannii isolates from patients with bacteremia in Turkey. Clin Lab 61:741–7.
41. Carbonne A, Thiolet JM, Fournier S, et al. (2010). Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 15:19734.
42. Carmeli Y, Akova M, Cornaglia G, et al. (2010). Controlling the spread of carbapenemase-producing Gram-negatives:therapeutic approach and infection control. Clin Microbiol Infect 16:102–11.
43. Carrer A, Poirel L, Eraksoy H, et al. (2008). Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 52:2950–4.
44. Carrer A, Poirel L, Yilmaz M, et al. (2010). Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 54:1369–73.
45. Castanheira M, Costello SE, Woosley LN, et al. (2014). Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii–Acinetobacter calcoaceticus complex and enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35. Antimicrob Agents Chemother 58:7358–66.
46. Cendejas E, Gomez-Gil R, Gomez-Sanchez P, Mingorance J. (2010). Detection and characterization of enterobacteriaceae producing metallo-beta-lactamases in a tertiary-care hospital in Spain. Clin Microbiol Infect 16:181–3.
47. Charfi-Kessis K, Mansour W, Ben Haj KA, et al. (2014). Multidrug-resistant Acinetobacter baumannii strains carrying the Bla(OxA-23) and the Bla(GES-11) genes in a neonatology center in Tunisia. Microb Pathog 74:20–4.
48. Chouchani C, Marrakchi R, El Salabi A. (2011a). Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia. Crit Rev Microbiol 37:167–77.
49. Chouchani C, Marrakchi R, Ferchichi L, et al. (2011b). VIM and IMP metallo-β-lactamases and other extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS 119:725–32.
50. Ciofi Degli AM, Bernaschi P, Carletti M, et al. (2014). An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy. BMC Infect Dis 14:494.
51. Compain F, Decre D, Frazier I, et al. (2014). Carbapenemase-producing bacteria in patients hospitalized abroad, France. Emerging Infect Dis 20:1246–8.
52. Cornaglia G, Giamarellou H, Rossolini GM. (2011). Metallo-β-lactamases:a last frontier for β-lactams? Lancet Infect Dis 11:381–93.
53. Cornaglia G, Mazzariol A, Lauretti L, et al. (2000). Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis 31:1119–25.
54. Cornaglia G, Riccio ML, Mazzariol A, et al. (1999). Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet 353:899–900.
55. Curiao T, Morosini MI, Ruiz-Garbajosa P, et al. (2010). Emergence of Bla KPC-3-Tn4401a associated with a PKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 65:1608–14.
56. Cuzon G, Bonnin RA, Nordmann P. (2013). First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One 8:e61322.
57. Cuzon G, Naas T, Demachy MC, Nordmann P. (2008). Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–7.
58. Cuzon G, Naas T, Demachy MC, Nordmann P. (2012). Nosocomial outbreak of Klebsiella pneumoniae harbouring Bla(KPC-3) in France subsequent to a patient transfer from Italy. Int J Antimicrob Agents 39:448–9.
59. Cuzon G, Naas T, Lesenne A, et al. (2010). Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents 36:91–3.
60. Cuzon G, Ouanich J, Gondret R, et al. (2011). Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55:2420–3.
61. De Boer D, de Jong EG, Maes RA. (1990). Mass spectrometric characterization of different norandrosterone derivatives by low-cost mass spectrometric detectors using electron ionization and chemical ionization. Rapid Commun Mass Spectrom 4:181–5.
62. Decre D, Birgand G, Geneste D, et al. (2010). Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Euro Surveill 15:19718.
63. Denis C, Poirel L, Carricajo A, et al. (2012). Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France. Clin Microbiol Infect 18:E128–30.
64. Di CP, Pantuso G, Cusimano A, et al. (2011). Two cases of monomicrobial intraabdominal abscesses due to KPC–3 Klebsiella pneumoniae ST258 clone. BMC Gastroenterol 11:103.
65. Diab M, Fam N, El-Dabaa E, et al. (2013). Occurrence of VIM-2 metallo-ß-lactamases in imipenem-resistant and -susceptible Pseudomonas aeruginosa clinical isolates from Egypt. Afr J Microbiol Res 7:4465–72.
66. Diene SM, Bruder N, Raoult D, Rolain JM. (2011). Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase(NDM-1)-encoding gene in France. Int J Antimicrob Agents 37:544–6.
67. Dimude JU, Amyes SG. (2013). Molecular characterisation and diversity in Enterobacter cloacae from Edinburgh and Egypt carrying Bla(CTX-M-14) and Bla(VIM-4) β-lactamase genes. Int J Antimicrob Agents 41:574–7.
68. Dortet L, Radu I, Gautier V, et al. (2008). Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated With OXA-9 and TEM-1. J Antimicrob Chemother 61:455–7.
69. El-Herte RI, Araj GF, Matar GM, et al. (2012). Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon. J Infect Dev Ctries 6:457–61.
70. El Salabi A, Borra PS, Toleman MA, et al. (2012). Genetic and biochemical characterization of a novel metallo-beta-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother 56:2241–5.
71. El Salabi A, Walsh TR, Chouchani C. (2013). Extended spectrum beta-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria. Crit Rev Microbiol 39:113–22.
72. El-Sayed-Ahmed MA, Amin MA, Tawakol WM, et al. (2015). High prevalence of Bla(NDM-1) carbapenemase-encoding gene and 16S RRNA ArmA methyltransferase gene among Acinetobacter baumannii clinical isolates in Egypt. Antimicrob Agents Chemother 59:3602–5.
73. Fontana C, Favaro M, Sarmati L, et al. (2010). Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 3:40.
74. Fouad M, Attia AS, Tawakkol WM, Hashem AM. (2013). Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis 17:e1252–4.
75. Franolic-Kukina I, Bedenic B, Budimir A, et al. (2011). Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian University Hospital. Int J Infect Dis 15:e706–9.
76. Gaibani P, Ambretti S, Berlingeri A, et al. (2011a). Outbreak of NDM-1-producing Enterobacteriaceae in Northern Italy, July to August 2011. Euro Surveill 16:20027.
77. Gaibani P, Ambretti S, Berlingeri A, et al. (2011b). Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital:surveillance period 1 March–30 September 2010. Euro Surveill 16:19800.
78. Giakkoupi P, Papagiannitsis CC, Miriagou V, et al. (2011). An update of the evolving epidemic of BlaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66:1510–13.
79. Giakkoupi P, Petrikkos G, Tzouvelekis LS, et al. (2003a). Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa Strains in Greek Hospitals. J Clin Microbiol 41:822–5.
80. Giakkoupi P, Tryfinopoulou K, Kontopidou F, et al. (2013). Emergence of NDM-producing Klebsiella pneumoniae in Greece. Diagn Microbiol Infect Dis 77:382–4.
81. Giakkoupi P, Xanthaki A, Kanelopoulou M, et al. (2003b). VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41:3893–6.
82. Giamarellou H, Poulakou G. (2009). Multidrug-resistant Gram-negative infections:what are the treatment options? Drugs 69:1879–901.
83. Giani T, D'Andrea MM, Pecile P, et al. (2009). Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J Clin Microbiol 47:3793–4.
84. Giani T, Conte V, Di P,V, et al., (2012a). Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother 56:2211–13.
85. Giani T, Marchese A, Coppo E, et al. (2012b). VIM-1-producing Pseudomonas mosselii isolates in Italy, predating known VIM-producing index strains. Antimicrob Agents Chemother 56:2216–17.
86. Girlich D, Bouihat N, Poirel L, et al. (2014). High rate of faecal carriage of extended-spectrum beta-lactamase and OXA-48 carbapenemase-producing enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect 20:350–4.
87. Girlich D, Nordmann P. (2015). CHROMagar acinetobacter medium for detection of carbapenemase-producing Acinetobacter Spp. strains from spiked stools. Diagn Microbiol Infect Dis 83:234–6.
88. Goic-Barisic I, Bedenic B, Tonkic M, et al. (2007). First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University Hospital Split, Croatia. J Chemother 19:462–4.
89. Goic-Barisic I, Bedenic B, Tonkic M, et al. (2009). Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. J Clin Microbiol 47:3348–9.
90. Goic-Barisic I, Towner KJ, Kovacic A, et al. (2011). Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 77:368–9.
91. Gomez-Gil MR, Pano-Pardo JR, Romero-Gomez MP, et al. (2010). Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother 65:2695–7.
92. Grundmann H, Livermore DM, Giske CG, et al. (2010). Carbapenem-non-susceptible enterobacteriaceae in Europe:conclusions from a meeting of national experts. Euro Surveill 15:46.
93. Guerrero-Lozano I, Fernandez-Cuenca F, Galan-Sanchez F, et al. A (2015) description of the OXA-23 beta-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain. Microb Drug Resist 21:215–17.
94. Gulmez D, Woodford N, Palepou MF, et al. (2008). Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 31:523–6.
95. Hammami S, Boutiba-Ben B,I, Ghozzi R, et al. (2011a). Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn Pathol 6:106.
96. Hammami S, Gautier V, Ghozzi R, et al. (2010). Diversity in VIM-2-encoding class 1 integrons and occasional BlaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect 16:189–93.
97. Hammami S, Ghozzi R, Saidani M, Ben RS. (2011b). Carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in Tunisia. Tunis Med 89:638–43.
98. Hammerum AM, Larsen AR, Hansen F, et al. (2012). Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 40:191–2.
99. Hammoudi D, Moubareck CA, Aires J, et al. (2014). Countrywide spread of OXA-48 carbapenemase in Lebanon:surveillance and genetic characterization of carbapenem-non-susceptible enterobacteriaceae in 10 hospitals over a one-year period. Int J Infect Dis 29:139–44.
100. Hays C, Benouda A, Poirel L, et al. (2012). Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan Hospital. Int J Antimicrob Agents 39:545–7.
101. Heydari F, Mammina C, Koksal F. (2015). NDM-1-producing Acinetobacter baumannii ST85 now in Turkey, including one isolate from a Syrian refugee. J Med Microbiol 64:1027–9.
102. Hrabak J, Stolbova M, Studentova V, et al. (2012). NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011. Euro Surveill 17:20085.
103. Ikonomidis A, Tokatlidou D, Kristo I, et al. (2005). Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a Bla VIM-1 metallo-{Beta}-lactamase gene. J Clin Microbiol 43:5344–7.
104. Iraz M, Duzgun AO, Cicek AC, et al. (2014). Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey. Diagn Microbiol Infect Dis 78:292–4.
105. Ito H, Arakawa Y, Ohsuka S, et al. (1995). Plasmid-mediated dissemination of the metallo-beta-lactamase gene BlaIMP among clinically isolated strains of Serratia Marcescens. Antimicrob Agents Chemother 39:824–9.
106. Janvier F, Jeannot K, Tesse S, et al. (2013). Molecular characterization of BlaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France. Antimicrob Agents Chemother 57:3408–11.
107. Jeannot K, Diancourt L, Vaux S, et al. (2014). Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France. PLoS One 9:e115452.
108. Jesudason MV, Kandathil AJ, Balaji V. (2005). Comparison of two methods to detect carbapenemase & metallo-beta- lactamase production in clinical isolates. Indian J Med Res 121:780–3.
109. Juan C, Beceiro A, Gutierrez O, et al. (2008). Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob Agents Chemother 52:3589–96.
110. Kaase M, Nordmann P, Wichelhaus TA, et al. (2011). NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 66:1260–2.
111. Kassis-Chikhani N, Decre D, Gautier V, et al. (2006). First outbreak of multidrug-resistant Klebsiella pneumoniae carrying BlaVIM-1 and BlaSHV-5 in a French university hospital. J Antimicrob Chemother 57:142–5.
112. Khorsi K, Messai Y, Hamidi M, et al. (2015). High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes BlaOXA-23-like, BlaOXA-24-Like and BlaNDM-1 in Algiers Hospitals. Asian Pac J Trop Med 8:438–46.
113. Kilic A, Aktas Z, Bedir O, et al. (2011). Identification and characterization of OXA-48 producing, carbapenem-resistant enterobacteriaceae isolates in Turkey. Ann Clin Lab Sci 41:161–6.
114. Kocsis E, Savio C, Piccoli M, et al. (2013). Klebsiella pneumoniae harbouring OXA-48 carbapenemase in a Libyan refugee in Italy. Clin Microbiol Infect 19:E409–11.
115. Kotsakis SD, Miriagou V, Tzelepi E, Tzouvelekis LS. (2010). Comparative biochemical and computational study of the role of naturally occurring mutations at ambler positions 104 and 170 in GES β-lactamases. Antimicrob Agents Chemother 54:4864–71.
116. Kristof K, Toth A, Damjanova I, et al. (2010). Identification of a BlaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. J Antimicrob Chemother 65:1303–5.
117. Ktari S, Arlet G, Mnif B, et al. (2006). Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 50:4198–201.
118. Ktari S, Mnif B, Louati F, et al. (2011). Spread of Klebsiella pneumoniae isolates producing OXA-48 beta-lactamase in a Tunisian university hospital. J Antimicrob Chemother 66:1644–6.
119. Lafeuille E, Decre D, Mahjoub-Messai F, et al. (2013). OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microb Drug Resist 19:491–7.
120. Lahlaoui H, Poirel L, Barguellil F, et al. (2012). Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia. Eur J Clin Microbiol Infect Dis 31:937–9.
121. Lartigue MF, Poirel L, Nordmann P. (2004). First detection of a carbapenem-hydrolyzing metalloenzyme in an enterobacteriaceae isolate in France. Antimicrob Agents Chemother 48:4929–30.
122. Lauretti L, Riccio ML, Mazzariol A, et al. (1999). Cloning and characterization of BlaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43:1584–90.
123. Levast M, Poirel L, Carrer A, et al. (2011). Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France. J Antimicrob Chemother 66:944–5.
124. Liakopoulos A, Mavroidi A, Katsifas EA, et al. (2013). Carbapenemase-producing Pseudomonas aeruginosa from Central Greece:molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis 13:505.
125. Liakopoulos A, Miriagou V, Katsifas EA, et al. (2012). Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill 17:20117.
126. Loli A, Tzouvelekis LS, Gianneli D, et al. (2008). Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests. Antimicrob Agents Chemother 52:1894–6.
127. Luzzaro F, Docquier JD, Colinon C, et al. (2004). Emergence in Klebsiella pneumoniae and enterobacter cloacae clinical isolates of the VIM-4 metallo-beta-lactamase encoded by a conjugative plasmid. Antimicrob Agents Chemother 48:648–50.
128. Mammina C, Palma DM, Bonura C, et al. (2010). Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol 48:1506–7.
129. Mansour W, Poirel L, Bettaieb D, et al. (2008). Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a university hospital in Tunisia. Microb Drug Resist 14:289–92.
130. Mansour W, Poirel L, Bettaieb D, et al. (2009). Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis 64:458–61.
131. Marchese A, Coppo E, Barbieri R, Debbia E. (2010). Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian Hospital. J Chemother 22:212–14.
132. Mathlouthi N, Areig Z, Al BC, et al. (2015). Emergence of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates collected from some Libyan Hospitals. Microb Drug Resist 21:335–41.
133. Mavroidi A, Likousi S, Palla E, et al. (2015). Molecular identification of tigecycline- and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013. J Med Microbiol 64:993–7.
134. Mavroidi A, Miriagou V, Malli E, et al. (2012). Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents 39:247–50.
135. Mazzariol A, Mammina C, Koncan R, et al. (2011). A novel VIM-type metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit. Clin Microbiol Infect 17:722–4.
136. Mesli E, Berrazeg M, Drissi M, et al. (2013). Prevalence of carbapenemase-encoding genes including New Delhi metallo-β-lactamase in acinetobacter species, Algeria. Int J Infect Dis 17:e739–43.
137. Metwally L, Gomaa N, Attallah M, Kamel N. (2013). High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. East Mediterr Health J 19:947–52.
138. Mezzatesta ML, Gona F, Caio C, et al. (2011). Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian Hospitals. Clin Microbiol Infect 17:1444–7.
139. Migliavacca R, Espinal P, Principe L, et al. (2013). Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy. Diagn Microbiol Infect Dis 75:180–6.
140. Miriagou V, Papagiannitsis CC, Kotsakis SD, et al. (2010). Sequence of PNL194, a 79.3-kilobase IncN plasmid carrying the BlaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 54:4497–502.
141. Miro E, Segura C, Navarro F, et al. (2010). Spread of plasmids containing the Bla(VIM-1) and Bla(CTX-M) genes and the Qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J Antimicrob Chemother 65:661–5.
142. Mugnier PD, Poirel L, Naas T, Nordmann P. (2010). Worldwide dissemination of the BlaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerging Infect Dis 16:35–40.
143. Mugnier P, Poirel L, Pitout M, Nordmann P. (2008). Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 14:879–82.
144. Naas T, Cuzon G, Babics A, et al. (2010). Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase. J Antimicrob Chemother 65:1305–6.
145. Naas T, Ergani A, Carrer A, Nordmann P. (2011). Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother 55:4038–43.
146. Naas T, Nordmann P. (1994). Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci USA 91:7693–7.
147. Naas T, Nordmann P, Vedel G, Poyart C. (2005). Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 49:4423–4.
148. Naas T, Vandel L, Sougakoff W, et al. (1994). Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia Marcescens S6. Antimicrob Agents Chemother 38:1262–70.
149. Nahid F, Khan AA, Rehman S, Zahra R. (2013). Prevalence of metallo-β-lactamase NDM-1-producing multi-drug resistant bacteria at two Pakistani hospitals and implications for public health. J Infect Public Health 6:487–93.
150. Nazic H, Poirel L, Nordmann P. (2005). Further identification of plasmid-mediated quinolone resistance determinant in enterobacteriaceae in Turkey. Antimicrob Agents Chemother 49:2146–7.
151. Nordmann P, Couard JP, Sansot D, Poirel L. (2012a). Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clin Infect Dis 54:150–1.
152. Nordmann P, Cuzon G, Naas T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–36.
153. Nordmann P, Dortet L, Poirel L. (2012b). Carbapenem resistance in enterobacteriaceae:here is the storm!. Trends Mol Med 18:263–72.
154. Nordmann P, Naas T, Poirel L. (2011a). Global spread of carbapenemase-producing enterobacteriaceae. Emerging Infect Dis 17:1791–8.
155. Nordmann P, Poirel L, Toleman MA, Walsh TR. (2011b). Does broad-spectrum beta-lactam resistance due to NDM-1 Herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689–92.
156. Ocampo-Sosa AA, Guzman-Gomez LP, Fernandez-Martinez M, et al. (2015). Isolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in Northern Spain. Antimicrob Agents Chemother 59:1334–6.
157. Oteo J, Hernandez-Almaraz JL, Gil-Anton J, et al. (2010). Outbreak of Vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 29:1144–6.
158. Pantel A, Marchandin H, Prere MF, et al. (2015). Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in Southern France. Eur J Clin Microbiol Infect Dis 34:899–904.
159. Patel G, Huprikar S, Factor SH, et al. (2008). Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099–106.
160. Perilli M, Sabatini A, Pontieri E, et al. (2015). OXA-23 carbapenemase in multidrug-resistant Acinetobacter baumannii ST2 type:first identification in L'Aquila Hospital (Italy). Microb Drug Resist 21:97–101.
161. Pfeifer Y, Cullik A, Witte W. (2010). Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 300:371–9.
162. Picao RC, Santos AF, Nicoletti AG, et al. (2010). Detection of GES-5-producing Klebsiella pneumoniae in Brazil. J Antimicrob Chemother 65:796–7.
163. Pirs M, Andlovic A, Cerar T, et al. (2011). A case of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a patient transferred to Slovenia from Libya, November 2011. Euro Surveill 16:20042.
164. Pitart C, Sole M, Roca I, et al. (2011). First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55:4398–401.
165. Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P. (2013). Occurrence of OXA-48 and VIM-1 carbapenemase-producing enterobacteriaceae in Egypt. Int J Antimicrob Agents 41:90–1.
166. Poirel L, Benouda A, Hays C, Nordmann P. (2011a). Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother 66:2781–3.
167. Poirel L, Bernabeu S, Fortineau N, et al. (2011b). Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob Agents Chemother 55:4937–8.
168. Poirel L, Fortineau N, Nordmann P. (2011c). International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 55:1821–2.
169. Poirel L, Heritier C, Tolun V, Nordmann P. (2004). Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22.
170. Poirel L, Le T,I, Naas T, et al. (2000a). Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44:622–32.
171. Poirel L, Naas T, Nicolas D, et al. (2000b). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891–7.
172. Poirel L, Pitout JD, Nordmann P. (2007). Carbapenemases:molecular diversity and clinical consequences. Future Microbiol 2:501–12.
173. Poirel L, Ros A, Carrer A, et al. (2011d). Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J Antimicrob Chemother 66:1181–2.
174. Poirel L, Ros A, Carricajo A, et al. (2011e). Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–8.
175. Potron A, Kalpoe J, Poirel L, Nordmann P. (2011a). European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 17:E24–6.
176. Potron A, Nordmann P, Lafeuille E, et al. (2011b). Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4896–9.
177. Potron A, Poirel L, Rondinaud E, Nordmann P. (2013). Intercontinental spread of OXA-48 beta-lactamase-producing enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 18:20549.
178. Pournaras S, Maniati M, Petinaki E, et al. (2003). Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants BlaVIM-2 and BlaVIM-4. J Antimicrob Chemother 51:1409–14.
179. Principe L, Piazza A, Giani T, et al. (2014). Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy:results of the first cross-sectional countrywide survey. J Clin Microbiol 52:3004–10.
180. Queenan AM, Bush K. (2007). Carbapenemases:the versatile beta-lactamases. Clin Microbiol Rev 20:440–58.
181. Rafei R, Pailhories H, Hamze M, et al. (2015). Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using Bla(OXA-51-Like) sequence based typing. BMC Microbiol 15:103.
182. Riccio ML, Franceschini N, Boschi L, et al. (2000). Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of Bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 44:1229–35.
183. Riccio ML, Pallecchi L, Docquier JD, et al. (2005). Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals. Antimicrob Agents Chemother 49:104–10.
184. Riccio ML, Pallecchi L, Fontana R, Rossolini GM. (2001). In70 of plasmid PAX22, a Bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother 45:1249–53.
185. Richter SN, Frasson I, Bergo C, et al. (2011). Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient:first case in Europe. J Clin Microbiol 49:2040–2.
186. Robin F, Aggoune-Khinache N, Delmas J, et al. (2010). Novel VIM metallo-beta-lactamase variant from clinical isolates of enterobacteriaceae from Algeria. Antimicrob Agents Chemother 54:466–470.
187. Robledo IE, Aquino EE, Sante MI, et al. (2010). Detection of KPC in Acinetobacter Spp. in Puerto Rico. Antimicrob Agents Chemother 54:1354–1357.
188. Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. (2010). VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother 54:471–6.
189. Rolain JM, Parola P, Cornaglia G. (2010). New Delhi metallo-beta-lactamase (NDM-1):towards a new pandemia? Clin Microbiol Infect 16:1699–1701.
190. Ruppe E, Armand-Lefevre L, Lolom I, et al. (2011). Development of a phenotypic method for detection of fecal carriage of OXA-48-producing enterobacteriaceae after incidental detection from clinical specimen. J Clin Microbiol 49:2761–2.
191. Saidani M, Hammami S, Kammoun A, et al., (2012). Emergence of carbapenem-resistant OXA-48 carbapenemase-producing enterobacteriaceae in Tunisia. J Med Microbiol 61:1746–9.
192. Samra Z, Ofir O, Lishtzinsky Y, et al. (2007). Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 30:525–9.
193. Samuelsen O, Naseer U, Tofteland S, et al. (2009). Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 63:654–8.
194. San Millan A, Toll-Riera M, Escudero JA, et al. (2015). Sequencing of plasmids PAMBL1 and PAMBL2 from Pseudomonas aeruginosa reveals a BlaVIM-1 amplification causing high-level carbapenem resistance. J Antimicrob Chemother 70:3000–3.
195. Sanchez-Romero I, Asensio A, Oteo J, et al. (2012). Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15:molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 56:420–7.
196. Sardelic S, Pallecchi L, Punda-Polic V, Rossolini GM. (2003). Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia. Emerging Infect Dis 9:1022–3.
197. Sassi A, Loucif L, Gupta SK, et al. (2014). NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother 58:5606–8.
198. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. (2008). Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028–33.
199. Scotta C, Juan C, Cabot G, et al. (2011). Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases. Antimicrob Agents Chemother 55:5376–9.
200. Sefraoui I, Berrazeg M, Drissi M, Rolain JM. (2014). Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from Western Algeria between 2009 and 2012. Microb Drug Resist 20:156–61.
201. Sevillano E, Gallego L, Garcia-Lobo JM. (2009). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris) 57:493–5.
202. Sole M, Pitart C, Roca I, et al. (2011). First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother 55:4402–4.
203. Sorli L, Miro E, Segura C, et al. (2011). Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient. Eur J Clin Microbiol Infect Dis 30:1551–5.
204. Souli M, Galani I, Antoniadou A, et al. (2010). An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital:molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50:364–73.
205. Souli M, Galani I, Giamarellou H. (2008). Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13:19045.
206. Tato M, Coque TM, Baquero F, Canton R. (2010). Dispersal of carbapenemase BlaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 54:320–7.
207. Tato M, Coque TM, Ruiz-Garbajosa P, et al. (2007). Complex clonal and plasmid epidemiology in the first outbreak of enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain:toward endemicity? Clin Infect Dis 45:1171–8.
208. Tortola MT, Lavilla S, Miro E, et al. (2005). First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother 49:3492–4.
209. Touati M, Diene SM, Dekhil M, et al. (2013). Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria. Antimicrob Agents Chemother 57:2426–7.
210. Touati M, Diene SM, Racherache A, et al. (2012). Emergence of BlaOXA-23 and BlaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from university hospital of Annaba, Algeria. Int J Antimicrob Agents 40:89–91.
211. Trevino M, Navarro D, Barbeito G, et al. (2011). Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight. Microb Drug Resist 17:433–42.
212. Tsakris A, Kristo I, Poulou A, et al. (2008). First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 62:1257–60.
213. Tsakris A, Pournaras S, Woodford N, et al. (2000). Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 38:1290–2.
214. Vatopoulos A. (2008). High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece–a review of the current evidence. Euro Surveill 13:8023.
215. Vidal-Navarro L, Pfeiffer C, Bouziges N, et al. (2010). Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a french university hospital. J Antimicrob Chemother 65:2455–8.
216. Viedma E, Juan C, Otero JR, et al. (2013). Draft genome sequence of VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175, an epidemic high-risk clone. Genome Announc 1:e0011213.
217. Voulgari E, Gartzonika C, Vrioni G, et al. (2014). The Balkan Region:NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. J Antimicrob Chemother 69:2091–7.
218. Voulgari E, Zarkotou O, Ranellou K, et al. (2013). Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 68:84–8.
219. Vourli S, Giakkoupi P, Miriagou V, et al. (2004). Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Lett 234:209–13.
220. Vranic-Ladavac M, Bedenic B, Minandri F, et al. (2014). Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009–2010. Eur J Clin Microbiol Infect Dis 33:471–8.
221. Walsh TR. (2010). Emerging carbapenemases:a global perspective. Int J Antimicrob Agents 36(Suppl 3):S8–14.
222. Walsh TR, Toleman MA, Poirel L, Nordmann P. (2005). Metallo-beta-lactamases:the quiet before the storm? Clin Microbiol Rev 18:306–25.
223. Walther-Rasmussen J, Hoiby N. (2007). Class A carbapenemases. J Antimicrob Chemother 60:470–82.
224. Yigit H, Queenan AM, Anderson GJ, et al. (2001). Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–61.
225. Zafer MM, Al-Agamy MH, El-Mahallawy HA, et al. (2014a). Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed Res Int 2014:101635.
226. Zafer MM, Amin M, El MH, et al. (2014b). First report of NDM-1-producing Pseudomonas aeruginosa in Egypt. Int J Infect Dis 29:80–1.
227. Zeka AN, Poirel L, Sipahi OR, et al. (2014). GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey. J Antimicrob Chemother 69:1145–6.
228. Zhao WH, Hu ZQ. (2011). Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol 6:317–33.